-+ 0.00%
-+ 0.00%
-+ 0.00%

ARROWHEAD PHARMACEUTICALS - TO USE VOUCHER FOR PLOZASIRAN SNDA IN SEVERE HYPERTRIGLYCERIDEMIA BEFORE END OF 2026

Reuters·08/04/2026 20:00:00

Please log in to view news